- Home
- CENN vs BIAF Comparison
CENN vs BIAF Comparison
Compare CENN & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- BIAF
- Stock Information
- Founded
- CENN 2013
- BIAF 2014
- Country
- CENN United States
- BIAF United States
- Employees
- CENN N/A
- BIAF N/A
- Industry
- CENN Auto Manufacturing
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CENN Consumer Discretionary
- BIAF Health Care
- Exchange
- CENN Nasdaq
- BIAF Nasdaq
- Market Cap
- CENN 8.2M
- BIAF 6.6M
- IPO Year
- CENN N/A
- BIAF 2022
- Fundamental
- Price
- CENN $0.16
- BIAF $1.46
- Analyst Decision
- CENN
- BIAF Hold
- Analyst Count
- CENN 0
- BIAF 1
- Target Price
- CENN N/A
- BIAF N/A
- AVG Volume (30 Days)
- CENN 6.4M
- BIAF 142.7K
- Earning Date
- CENN 11-12-2025
- BIAF 11-14-2025
- Dividend Yield
- CENN N/A
- BIAF N/A
- EPS Growth
- CENN N/A
- BIAF N/A
- EPS
- CENN N/A
- BIAF N/A
- Revenue
- CENN $18,529,541.00
- BIAF $6,776,739.00
- Revenue This Year
- CENN N/A
- BIAF N/A
- Revenue Next Year
- CENN N/A
- BIAF $20.04
- P/E Ratio
- CENN N/A
- BIAF N/A
- Revenue Growth
- CENN N/A
- BIAF N/A
- 52 Week Low
- CENN $0.13
- BIAF $1.25
- 52 Week High
- CENN $1.33
- BIAF $46.53
- Technical
- Relative Strength Index (RSI)
- CENN 29.92
- BIAF 34.99
- Support Level
- CENN $0.14
- BIAF $1.91
- Resistance Level
- CENN $0.16
- BIAF $1.57
- Average True Range (ATR)
- CENN 0.02
- BIAF 0.20
- MACD
- CENN 0.01
- BIAF -0.06
- Stochastic Oscillator
- CENN 31.92
- BIAF 20.38
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.